Spanish Company Indukern Slows Acquisition ProcessJune 2012 | Industry Trend Analysis
BMI View: We previously highlighted that Spanish pharmaceutical companies have increased their Latin American presence due to their deteriorating domestic market. However, compared to its neighbours, the attractiveness of Argentina's pharmaceutical market to drug companies is decreasing, due to its unsustainable macroeconomic trajectory and the resurgence of nationalism. The market has a double-digit growth rate, measured in local currency terms, although this is due in large part to the high inflation rate.
To read the full article, please choose one of the following options: